Risk of macular degeneration in users of statins: cross sectional study

Atherosclerosis and abnormalities of lipid metabolism are associated with an increased risk of age related macular degenerationthe Western world's main cause of blindness. Statins (hydroxymethyl glutaryl coenzyme A reductase inhibitors) modify patients' lipid profile and lower their risk of coronary heart disease. They also prevent stroke and, possibly, Alzheimer's disease. We report here an association between statin use and lower risk of age related macular degeneration